5 Key Takeaways

• 1

  Tenpoint Therapeutics launched a national campaign for YUVEZZI, a prescription eye drop for presbyopia, approved by the FDA.

• 2

  The campaign, titled Friends of the Presbyopians, features puppets to illustrate frustrations with blurry close-up vision.

• 3

  YUVEZZI is a dual-agent solution containing carbachol and brimonidine tartrate, approved for adults with age-related blurry near vision.

• 4

  Presbyopia affects about 128 million adults in the US and approximately 2 billion people globally, typically starting around age 45.

• 5

  YUVEZZI has shown to provide up to eight continuous hours of improved close-up vision, with common side effects including headache and eye irritation.